Longitudinal analysis showed that PRF1 mean expression in cluster 5 was higher in TILT trial patients compared with Treg-T1D trial patients at day 7 after the first course of IL-2 (Figure 6D). This evidence concerns the gene PRF1 and type 1 diabetes mellitus.